Operating

Goodwill and other intangible asset impairment charges

Year-over-year, this metric declined by 100.0%, from $379.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026

How to read this metric

A significant impairment charge often signals poor past acquisition performance or a decline in the competitive position of a business unit.

Detailed definition

This represents a non-cash charge taken when the carrying value of an intangible asset, such as goodwill or a brand name...

Peer comparison

Occurs periodically across all industries; high frequency may indicate poor capital allocation discipline.

Metric ID: operating_impairment_of_intangible_assets_indefinitelive_3dfac8

Historical Data

13 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$379.00M$0.00$0.00$0.00$0.00
QoQ Change-100.0%
YoY Change-100.0%
Range$0.00$379.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Business Segments

View all
SegmentQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Pharmaceuticals$379.00M$0.00$0.00$0.00$0.00
Total$379.00M$0.00$0.00$0.00$0.00

Frequently Asked Questions

What is Vertex Pharmaceuticals's goodwill and other intangible asset impairment charges?
Vertex Pharmaceuticals (VRTX) reported goodwill and other intangible asset impairment charges of $0.00 in Q1 2026.
How has Vertex Pharmaceuticals's goodwill and other intangible asset impairment charges changed year-over-year?
Vertex Pharmaceuticals's goodwill and other intangible asset impairment charges decreased by 100.0% year-over-year, from $379.00M to $0.00.
What does goodwill and other intangible asset impairment charges mean?
A non-cash write-down of the value of intangible assets that are no longer worth their recorded amount.